Clinical Trials · NCT07247084
A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Eli Lilly and Company
- Enrollment
- 3,000
- Start date
- Nov 2025
- Locations
- 30 sites, United Kingdom
- Primary endpoint
- Percent Change from Baseline in Body Weight